API5 has been shown to be upregulated in various cancers, such as breast cancer, colorectal cancer, cervical cancer, NSCLC, or B-cell chronic lymphoid leukemia [26,28,29,30,31,32,33,35,86,115,116]. This evidence concerns the gene API5 and breast carcinoma.